Fibrinogen and red blood cells in venous thrombosis.

Abstract

Deep vein thrombosis and pulmonary embolism, collectively termed venous thromboembolism (VTE), affect over 1 million Americans each year. VTE is triggered by inflammation and blood stasis leading to the formation of thrombi rich in fibrin and red blood cells (RBCs). However, little is known about mechanisms regulating fibrin and RBC incorporation into venous thrombi, or how these components mediate thrombus size or resolution. Both elevated circulating fibrinogen (hyperfibrinogenemia) and abnormal fibrin(ogen) structure and function, including increased fibrin network density and resistance to fibrinolysis, have been observed in plasmas from patients with VTE. Abnormalities in RBC number and/or function have also been associated with VTE risk. RBC contributions to VTE are thought to stem from their effects on blood viscosity and margination of platelets to the vessel wall. More recent studies suggest RBCs also express phosphatidylserine, support thrombin generation, and decrease fibrinolysis. RBC interactions with fibrin(ogen) and cells, including platelets and endothelial cells, may also promote thrombus formation. The contributions of fibrin(ogen) and RBCs to the pathophysiology of VTE warrants further investigation.

• Authors: Maria M Aleman, Bethany L Walton, James R Byrnes, Alisa S Wolberg
• Journal: Thrombosis research (Thromb Res) Vol. 133 Suppl 1 Pg. S38-40 (May 2014) ISSN: 1879-2472 [Electronic] United States
• PMID: 24759140 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
• Copyright: Copyright © 2014 Elsevier Ltd. All rights reserved.

Chemical References

• Fibrinogen

Topics

• Animals
• Blood Coagulation
• Erythrocytes (metabolism, pathology)
• Fibrinogen (analysis, metabolism)
• Humans
• Veins (metabolism, pathology)
• Venous Thrombosis (blood, metabolism, pathology)